ADMA Biologics (ADMA)
US Market

ADMA Biologics Cash flow


ADMA Biologics Cash Flow

ADMA's free cash flow for Q3 2022 was $-16.67M. For the 2022 fiscal year, ADMA's free cash flow was decreased by $-11.15M and operating cash flow was $-13.28M. See a summary of the company’s cash flow.
Cash Flow
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -85.59M$ -112.37M$ -102.00M$ -76.19M$ -62.68M$ -37.27M
Investing Cash Flow
$ -13.84M$ -13.51M$ -12.72M$ -3.81M$ -2.10M$ 15.21M
Financing Cash Flow
$ 99.93M$ 121.05M$ 143.90M$ 80.00M$ 42.92M$ 60.75M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 207.92M$ 51.09M$ 55.92M$ 26.75M$ 26.75M$ 48.61M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
--$ 10.27M$ 8.11M--
Issuance Of Capital Stock
$ 53.83M$ 121.14M$ 131.20M$ 48.40M$ 42.94M$ 39.20M
Issuance Of Debt
$ 151.75M$ 0.00$ 27.50M$ 72.50M$ 0.00$ 45.00M
Repayment Of Debt
$ -100.04M$ -34.30K$ -13.98M$ -30.03M$ -36.28K$ -20.02M
Free Cash Flow
$ -99.43M$ -125.88M$ -114.73M$ -80.01M$ -64.77M$ -39.95M
Domestic Sales
Foreign Sales
Currency in USD

ADMA Biologics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis